Healthcare investor Syncona said an indicative pricing range for an initial public offering of portfolio company Freeline Therapeutics would represent an increase in the value...
UK stocks reversed opening softness to put in a late morning surge on Monday as investors shrugged-off geopolitical worries and soaring losses posted by HSBC,...
Barclays Capital today reaffirms its overweight investment rating on Lloyds Banking Group PLC ORD (LON:LLOY) and cut its price target to 45p (from 50p).
Cannabidiol group Zoetic International said the completion of a proposed sale of its DTU and its Kansas nitrogen assets to Path Investments had been delayed....
Law and professional services group Ince reported that adjusted profit rose by more than a third despite 'narrowly' missing its £100m revenue target amid disruption...
Barclays Capital today reaffirms its overweight investment rating on Hargreaves Lansdown PLC (LON:HL.) and raised its price target to 1770p (from 1735p).